MediciBioㅣ메디치바이오

Nowadays, “Medici effect” means “a phenomenon in which innovative ideas explode at the intersection of different ideas”, emphasizing the importance of innovation through converging technologies.

In line with the big trend of biopharmaceuticals on gene therapy, the aim of MediciBIO is to preempt an innovative original technology for gene therapy through integration of genetic biotechnology, innovative drug delivery system, and robust CMC strategy.

MediciBIO develops innovative new drugs against genetic and rare diseases and core platform technologies for efficient delivery of gene therapeutics with a vision to become a global specialty company in the gene therapy market that is estimated to expand over the next 30 years.

MediciBIO is established to develop novel gene therapy technology by converging knowledge in the fields of new drug development, drug delivery, and genetic biotechnology.

Nowadays, “Medici effect” means “a phenomenon in which innovative ideas explode at the intersection of different ideas”, emphasizing the importance of innovation through converging technologies.

In line with the big trend of biopharmaceuticals on gene therapy, the aim of MediciBIO is to preempt an innovative original technology for gene therapy through integration of genetic biotechnology, innovative drug delivery system, and robust CMC strategy.

MediciBIO develops innovative new drugs against genetic and rare diseases and core platform technologies for efficient delivery of gene therapeutics with a vision to become a global specialty company in the gene therapy market that is estimated to expand over the next 30 years.

ABOUT US

OVERVIEW

MediciBIO is established to develop novel gene therapy technology by converging knowledge in the fields of new drug development, drug delivery, and genetic biotechnology.

Nowadays, “Medici effect” means “a phenomenon in which innovative ideas explode at the intersection of different ideas”, emphasizing the importance of innovation through converging technologies.

In line with the big trend of biopharmaceuticals on gene therapy, the aim of MediciBIO is to preempt an innovative original technology for gene therapy through integration of genetic biotechnology, innovative drug delivery system, and robust CMC strategy.

MediciBIO develops innovative new drugs against genetic and rare diseases and core platform technologies for efficient delivery of gene therapeutics with a vision to become a global specialty company in the gene therapy market that is estimated to expand over the next 30 years.

VISION

MediciBIO aims to grow as a global biotechnology company through the gene therapy platform technology and the development of innovative new drug for intractable genetic diseases.